Pathophysiology and Treatment of Osteoarthritis

Osteoarthritis is a multifactorial degenerative joint disorder characterised by progressive articular cartilage loss, subchondral bone remodelling and synovial inflammation. Initiated by mechanical stress or metabolic derangements, the disease involves an imbalance between anabolic repair and catabolic degradation of the extracellular matrix. Chondrocytes, the sole cellular component of cartilage, respond to injury with altered metabolism and cytokine release, leading to upregulation of matrix metalloproteinases and aggrecanases. Concurrent synovial inflammation perpetuates low-grade inflammatory signalling, while subchondral bone sclerosis and osteophyte formation alter joint biomechanics. Clinically, patients experience pain, stiffness and reduced mobility. Current management focuses on symptom relief through pain control, weight management, physiotherapy and intra-articular injections. Joint replacement remains the definitive option for advanced disease. Emerging interventions aim to modify disease pathways by targeting inflammatory mediators, restoring cartilage homeostasis via cell-based therapies or gene delivery and inhibiting degradative enzymes. Advances in understanding molecular regulators of cartilage integrity and joint inflammation have spawned new preclinical strategies with potential to slow or reverse disease progression.

Research from Nature Portfolio

Recent studies have uncovered a reciprocal antagonism between Hippo-YAP signalling and NF-κB–driven inflammation in osteoarthritic cartilage. Activation of YAP preserves cartilage integrity by inhibiting TAK1-mediated NF-κB activation and reducing expression of matrix-degrading enzymes. Conversely, inflammatory cytokines trigger YAP degradation, amplifying catabolic processes. This work identifies YAP as both necessary and sufficient for cartilage homeostasis and suggests that modulation of Hippo pathway kinases or stabilisation of YAP could offer a novel disease-modifying approach.

Pathophysiology and Treatment of Osteoarthritis publication trend

The graph below shows the total number of articles in pathophysiology and treatment of osteoarthritis across all publications each year (not limited to Nature Index journals).

Technical terms

Chondrocyte: Cartilage cell responsible for synthesis and maintenance of the cartilage extracellular matrix.

Synovium: Membrane lining the joint capsule that produces synovial fluid and can mediate inflammatory responses.

Extracellular matrix (ECM): Network of collagens, proteoglycans and glycoproteins that provides structural support to cartilage.

NF-κB: Transcription factor central to pro-inflammatory signalling and induction of catabolic enzymes in joint tissues.

YAP/TAZ: Effectors of the Hippo pathway that regulate cell proliferation and survival; their activation promotes cartilage homeostasis by opposing inflammatory cues.

References

1. Reciprocal inhibition of YAP/TAZ and NF-κB regulates osteoarthritic cartilage degradation. Nature Communications (2018).
2. The potential role of synovial cells in the progression and treatment of osteoarthritis. Exploration (2023).
3. Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression. Bone Research (2023).
4. IRE1α protects against osteoarthritis by regulating progranulin-dependent XBP1 splicing and collagen homeostasis. Experimental & Molecular Medicine (2023).